
Diane LamarreUniversité de Montréal | UdeM · Faculty of Pharmacy
Diane Lamarre
About
19
Publications
1,995
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
506
Citations
Citations since 2017
Publications
Publications (19)
Primary care providers’ knowledge, attitudes and beliefs (KAB) regarding chronic noncancer pain (CNCP) are a barrier to optimal management.
OBJECTIVES: To evaluate and identify the determinants of the KAB of primary care physicians and pharmacists, and to document clinician preferences regarding the content and format of a continuing education prog...
Objectives To evaluate the impact of a debate on pharmacy students' perceptions, using online pharmacy practice as the debate topic.
Methods This is a quasi-experimental interrupted time-series study. A 60 min debate was organized as a lunchtime meeting. A four-category Likert scale questionnaire (fully agree, partially agree, partially disagree, f...
Objective In patients with chronic kidney disease (CKD), blood-pressure (BP) control is crucial. ProFiL, a training and communication-network programme, is designed to optimize community pharmacists' management of drug-related problems among CKD outpatients. This study evaluates the impact of ProFiL on BP control and management of hypertension trea...
Background / Purpose:
Better clinician education is often suggested as a means for improving the management of non-cancer chronic pain (NCCP). The KnowPain -50 is a recently validated tool measuring physician education needs and effectiveness of chronic pain educational programs. The objectives of this study were to adapt the questionnaire for us...
Background:
Collaborative practices allow physicians and pharmacists to comanage pharmacotherapy to maximize the benefits of medication regimens. The Trial to Evaluate an Ambulatory primary care Management program for patients with dyslipidemia (TEAM) study compared the efficacy of a physician-pharmacist collaborative primary care (PPCC) intervent...
Few studies have reported the efficacy of collaborative care involving family physicians and community pharmacists for patients with dyslipidemia.
We randomly assigned clusters consisting of at least two physicians and at least four pharmacists to provide collaborative care or usual care. Under the collaborative care model, pharmacists counselled p...
Access to medications and their proper use are essential in developing countries. An interdisciplinary team of dermatologists and pharmacists created a master list of preparations useful for treating the most common dermatologic disorders in tropical and equatorial areas. The first pilot project was done at Cardinal Leger Hospital in Leogane, Haiti...
Introduction: In a physician-pharmacist collaborative-care (PPCC) intervention, community pharmacists were responsible for initiating lipid-lowering pharmacotherapy and adjusting the medication dosage. They attended a 1-day interactive workshop supported by a treatment protocol and clinical and communication tools. Afterwards, changes in pharmacist...
Dyslipidemia management in primary care is often sub-optimal. New Quebec (Canada) legislation increases the potential for family physician-community pharmacist collaborative care (PPCC). We hypothesized that PPCC can improve the management of dyslipidemia. In a randomized controlled trial, clusters of physicians and pharmacists within the same geog...
To assess the feasibility and impact of implementing ProFiL program to optimize community-pharmacist management of drug-related problems among chronic kidney disease patients followed in a predialysis clinic. The program comprises a training workshop, communication-network program and consultation service.
Forty-two community pharmacies, 101 pharma...
D yslipidemia treatment in primary care is far from optimal — adherence and persistence to pharmacotherapy are low, and physicians tend not to titrate statin dosages. 1-6 Consequently, a large proportion of patients do not attain their recommended lipid targets. 6-8 This has serious clinical and economic consequences. 9 Several studies have shown t...
Use of over-the-counter medications and natural products may be associated with drug-related problems among patients with chronic renal insufficiency. The aim of this study is to describe the use of nonprescription medications in patients attending a predialysis clinic and identify drug-related problems associated with the use of these products.
In...
The impact of a community pharmacist telephone follow-up intervention (PTFI) on clinical outcomes, pharmaceutical care, and costs for patients undergoing antibiotic treatment was studied.
Patients receiving usual pharmacist intervention (UPI) were compared with PTFI patients in a multicenter, randomized, controlled trial.
Compared with the UPI grou...
Antihypertensive agents have been found to decrease morbidity and/or mortality associated with cardiovascular disease (CVD). Surveys have shown that hypertension has been diagnosed in many patients but remains uncontrolled. One factor may be the lack of persistence to treatment.
To evaluate persistence with antihypertensives and its determinants am...
Aims:
Statins have been shown to significantly reduce morbidity and mortality in patients with coronary artery disease (CAD), and also in patients with dyslipidaemia when statins are taken regularly. Middle-aged patients have the highest level of forecasting benefit and little is known about persistence rate of these therapies in a real-life setti...
Founded in 1985, Pharmaciens Sans Frontières (PSF) is a nongovemmental organization of pharmacists involved in humanitarian aid. PSF relied on approximately 100 expatriates in 1998, which included 50 pharmacists distributed throughout 24 missions (i.e., 14 emergency, 7 development, 3 assessment). It is necessary to add 200-250 local staff to this g...